Logo image of VIV.PA

VIVENDI SE (VIV.PA) Stock Fundamental Analysis

EPA:VIV - Euronext Paris - Matif - FR0000127771 - Common Stock - Currency: EUR

2.618  +0.01 (+0.5%)

Fundamental Rating

2

Overall VIV gets a fundamental rating of 2 out of 10. We evaluated VIV against 43 industry peers in the Entertainment industry. While VIV seems to be doing ok healthwise, there are quite some concerns on its profitability. VIV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year VIV has reported negative net income.
VIV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VIV reported negative net income in multiple years.
VIV had a positive operating cash flow in each of the past 5 years.
VIV.PA Yearly Net Income VS EBIT VS OCF VS FCFVIV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

With a Return On Assets value of -75.72%, VIV is not doing good in the industry: 93.02% of the companies in the same industry are doing better.
The Return On Equity of VIV (-130.75%) is worse than 76.74% of its industry peers.
Industry RankSector Rank
ROA -75.72%
ROE -130.75%
ROIC N/A
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
VIV.PA Yearly ROA, ROE, ROICVIV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

1.3 Margins

VIV's Gross Margin of 28.96% is on the low side compared to the rest of the industry. VIV is outperformed by 79.07% of its industry peers.
VIV's Gross Margin has declined in the last couple of years.
VIV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
VIV.PA Yearly Profit, Operating, Gross MarginsVIV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

4

2. Health

2.1 Basic Checks

VIV does not have a ROIC to compare to the WACC, probably because it is not profitable.
VIV has less shares outstanding than it did 1 year ago.
VIV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for VIV is higher compared to a year ago.
VIV.PA Yearly Shares OutstandingVIV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIV.PA Yearly Total Debt VS Total AssetsVIV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

VIV has an Altman-Z score of 0.94. This is a bad value and indicates that VIV is not financially healthy and even has some risk of bankruptcy.
VIV has a Altman-Z score (0.94) which is in line with its industry peers.
The Debt to FCF ratio of VIV is 1.46, which is an excellent value as it means it would take VIV, only 1.46 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.46, VIV is in the better half of the industry, outperforming 79.07% of the companies in the same industry.
A Debt/Equity ratio of 0.54 indicates that VIV is somewhat dependend on debt financing.
VIV's Debt to Equity ratio of 0.54 is in line compared to the rest of the industry. VIV outperforms 51.16% of its industry peers.
Even though the debt/equity ratio score it not favorable for VIV, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.46
Altman-Z 0.94
ROIC/WACCN/A
WACC5.92%
VIV.PA Yearly LT Debt VS Equity VS FCFVIV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

VIV has a Current Ratio of 0.24. This is a bad value and indicates that VIV is not financially healthy enough and could expect problems in meeting its short term obligations.
VIV has a Current ratio of 0.24. This is amonst the worse of the industry: VIV underperforms 93.02% of its industry peers.
A Quick Ratio of 0.24 indicates that VIV may have some problems paying its short term obligations.
VIV has a Quick ratio of 0.24. This is amonst the worse of the industry: VIV underperforms 93.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
VIV.PA Yearly Current Assets VS Current LiabilitesVIV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

More info and screens

1

3. Growth

3.1 Past

VIV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1628.21%.
Looking at the last year, VIV shows a decrease in Revenue. The Revenue has decreased by -4.81% in the last year.
The Revenue for VIV have been decreasing by -54.89% on average. This is quite bad
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2857.24%
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-100%

3.2 Future

Based on estimates for the next years, VIV will show a very strong growth in Earnings Per Share. The EPS will grow by 143.58% on average per year.
VIV is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -66.39% yearly.
EPS Next Y528.3%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
EPS Next 5YN/A
Revenue Next Year-96.39%
Revenue Next 2Y-80.76%
Revenue Next 3Y-66.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIV.PA Yearly Revenue VS EstimatesVIV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
VIV.PA Yearly EPS VS EstimatesVIV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VIV. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 34.39, which means the current valuation is very expensive for VIV.
Based on the Price/Forward Earnings ratio, VIV is valued a bit cheaper than the industry average as 60.47% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.32. VIV is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 34.39
VIV.PA Price Earnings VS Forward Price EarningsVIV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

VIV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VIV is cheaper than 97.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.47
EV/EBITDA N/A
VIV.PA Per share dataVIV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

VIV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as VIV's earnings are expected to grow with 143.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y194.68%
EPS Next 3Y143.58%

More info and screens

2

5. Dividend

5.1 Amount

VIV has a Yearly Dividend Yield of 1.54%.
VIV's Dividend Yield is rather good when compared to the industry average which is at 1.90. VIV pays more dividend than 83.72% of the companies in the same industry.
VIV's Dividend Yield is slightly below the S&P500 average, which is at 2.46.
Industry RankSector Rank
Dividend Yield 1.54%

5.2 History

The dividend of VIV decreases each year by -13.55%.
Dividend Growth(5Y)-13.55%
Div Incr Years0
Div Non Decr Years2
VIV.PA Yearly Dividends per shareVIV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

VIV has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-4.23%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
VIV.PA Yearly Income VS Free CF VS DividendVIV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

More info and screens

VIVENDI SE

EPA:VIV (4/28/2025, 5:29:52 PM)

2.618

+0.01 (+0.5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-06 2025-03-06/amc
Earnings (Next)04-28 2025-04-28
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners30.02%
Ins Owner ChangeN/A
Market Cap2.70B
Analysts70
Price Target3.05 (16.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.54%
Yearly Dividend0.25
Dividend Growth(5Y)-13.55%
DP-4.23%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-21.05%
PT rev (3m)-63.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.61%
EPS NY rev (3m)-91.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-98.42%
Revenue NY rev (3m)-98.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 34.39
P/S 9.08
P/FCF 1.47
P/OCF 1.47
P/B 0.59
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-5.96
EYN/A
EPS(NY)0.08
Fwd EY2.91%
FCF(TTM)1.78
FCFY68.13%
OCF(TTM)1.79
OCFY68.24%
SpS0.29
BVpS4.46
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.72%
ROE -130.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.96%
FCFM 618.52%
ROA(3y)-25.96%
ROA(5y)-0.02%
ROE(3y)-44.73%
ROE(5y)1.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.13%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z 0.94
F-Score4
WACC5.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)44.94%
Cap/Sales(5y)29.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1628.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2857.24%
EPS Next Y528.3%
EPS Next 2Y194.68%
EPS Next 3Y143.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.81%
Revenue growth 3Y-67.58%
Revenue growth 5Y-54.89%
Sales Q2Q%-100%
Revenue Next Year-96.39%
Revenue Next 2Y-80.76%
Revenue Next 3Y-66.39%
Revenue Next 5YN/A
EBIT growth 1Y-58.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.83%
EBIT Next 3Y23.29%
EBIT Next 5YN/A
FCF growth 1Y236.45%
FCF growth 3Y16%
FCF growth 5Y16.53%
OCF growth 1Y93.48%
OCF growth 3Y3.97%
OCF growth 5Y7.73%